In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota

American Journal of Clinical Nutrition

Volumn 97, Issue 2, 2013, Pages 295-309

  Bode, Lisa M ^a   Bunzel, Diana ^a   Huch, Melanie ^a   Cho, Gyu Sung ^a   Ruhland, Denise ^a   Bunzel, Mirko ^c   Bub, Achim ^b   Franz, Charles M A P ^a   Kulling, Sabine E ^a  

^a FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

^b Department of Physiology and Biochemistry of Nutrition ^*  (Germany)

^c KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3,4' DIHYDROXY STILBENE; BIBENZYL DERIVATIVE; DIHYDRORESVERATROL; LUNULARIN; RESVERATROL; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ADLERCREUTZIA EQUOLIFACIENS; ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; FEMALE; FERMENTATION; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLORA; LIQUID CHROMATOGRAPHY; MALE; METABOLISM; MICROBIAL DIVERSITY; NONHUMAN; NORMAL HUMAN; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; SLACKIA EQUOLIFACIENS; ULTRAVIOLET SPECTROSCOPY; URINALYSIS;

ACTINOBACTERIA; ADULT; BIBENZYLS; DIETARY SUPPLEMENTS; FECES; FEMALE; FERMENTATION; HUMANS; HYDROXYLATION; KINETICS; MALE; MIDDLE AGED; MOLECULAR STRUCTURE; MOLECULAR TYPING; PHENOLS; STEREOISOMERISM; STILBENES; YOUNG ADULT;

EID: 84873368632     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.049379     Document Type: Article

References (58)

1. Zamora-Ros R, Andres-Lacueva C, Lamuela-Raventos RM, Berenguer T, Jakszyn P, Martinez C, Sanchez MJ, Navarro C, Chirlaque MD, Tormo M-J, et al. Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort. Br J Nutr 2008; 100: 188-96.
2. Fauconneau B, WaffoTeguo P, Huguet F, Barrier L, Decendit A, Merillon JM. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci 1997; 61: 2103-10.
3. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993; 341: 1103-4.
4. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn AD, Mehta RG, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275: 218-20.
5. Pace-asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet-aggregation and eicosanoid synthesis - implication for protection against coronary heart-disease. Clin Chim Acta 1995; 235: 207-19.
6. Wang Z, Zou JG, Huang YZ, Cao KJ, Xu YN, Wu JM. Effect of re-sveratrol on platelet aggregation in vivo and in vitro. Chin Med J (Engl) 2002; 115: 378-80.
7. Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 1997; 94: 14138-43.
8. Mutoh M, Takahashi M, Fukuda K, Matsushima-Hibiya Y, Mutoh H, Sugimura T, Wakabayashi K. Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis 2000; 21: 959-63.
9. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444: 337-42.
10. Bass TM, Weinkove D, Houthoofd K, Gems D, Partridge L. Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech Ageing Dev 2007; 128: 546-52.
11. de Lorgeril M, Salen P, Guiraud A, Boucher E, de Leiris J. Resveratrol and non-ethanolic components of wine in experimental cardiology. Nutr Metab Cardiovasc Dis 2003; 13: 100-3.
12. Petrovski G, Gurusamy N, Das DK. Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci 2011; 1215: 22-33.
13. Catalgol B, Batirel S, Taga Y, Ozer NK. Resveratrol: French paradox revisited. Front Pharmacol 2012; 3:141.
14. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 2007; 224: 274-83.
15. Wenzel E, Soldo T, Erbersdobler H, Somoza V. Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol Nutr Food Res 2005; 49: 482-94.
16. Min/+ mice. J Nutr 2004; 134: 5-10.
17. Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 2004; 32: 1377-82.
18. Wang D, Hang TJ, Wu CY, Liu WY. Identification of the major metabolites of resveratrol in rat urine by HPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 829: 97-106.
19. Burkon A, Somoza V. Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O- conjugated diglucuronides - two novel resveratrol metabolites in human plasma. Mol Nutr Food Res 2008; 52: 549-57.
20. Azorin-Ortuño M, Yanez-Gascon MJ, Vallejo F, Pallares FJ, Larrosa M, Lucas R, Morales JC, Tomas-Barberan FA, Garcia-Conesa MT, Espin JC. Metabolites and tissue distribution of resveratrol in the pig. Mol Nutr Food Res 2011; 55: 1154-68.
21. Jung CM, Heinze TM, Schnackenberg LK, Mullis LB, Elkins SA, Elkins CA, Steele RS, Sutherland JB. Interaction of dietary resveratrol with animal-associated bacteria. FEMS Microbiol Lett 2009; 297: 266-73.
22. Del Rio D, Rodriguez-Mateos A, Spencer JPE, Tognolini M, Borges G, Crozier A. Dietary (poly) phenolics in human health: structures, bio-availability, and evidence of protective effects against chronic diseases Antioxid Redox Signaling (Epub ahead of print 27 August 2012).
23. Blaut M, Schoefer L, Braune A. Transformation of flavonoids by intestinal microorganisms. Int J Vitam Nutr Res 2003; 73: 79-87.
24. Rechner AR, Smith MA, Kuhnle G, Gibson GR, Debnam ES, Srai SKS, Moore KP, Rice-Evans CA. Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Radic Biol Med 2004; 36: 212-25.
25. Rowland IR, Wiseman H, Sanders TA, Adlercreutz H, Bowey EA. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 2000; 36: 27-32.
26. Bowey E, Adlercreutz H, Rowland I. Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem Toxicol 2003; 41: 631-6.
27. Joannou GE, Kelly GE, Reeder AY, Waring M, Nelson C. A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids. J Steroid Biochem Mol Biol 1995; 54: 167-84.
28. Gottlieb HE, Kotlyar V, Nudelman A. NMR chemical shifts of common laboratory solvents as trace impurities. J Org Chem 1997; 62: 7512-5.
29. Yu Z, Morrison M. Improved extraction of PCR-quality community DNA from digesta and fecal samples. Biotechniques 2004; 36: 808-12.
30. Nossa CW, Oberdorf WE, Yang L, Aas JA, Paster BJ, DeSantis TZ, Brodie EL, Malamud D, Poles MA, Pei Z. Design of 16S rRNA gene primers for 454 pyrosequencing of the human foregut microbiome. World J Gastroenterol 2010; 16: 4135-44.
31. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
32. Rinttilä T, Kassinen A, Malinen E, Krogius L, Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 2004; 97: 1166-77.
33. Guo X, Xia X, Tang R, Zhou J, Zhao H, Wang K. Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Lett Appl Microbiol 2008; 47: 367-73.
34. Malinen E, Kassinen A, Rinttila T, Palva A. Comparison of real-time PCR with SYBR Green I or 5 '-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Microbiology 2003; 149: 269-77.
35. Lee DH, Zo YG, Kim SJ. Nonradioactive method to study genetic profiles of natural bacterial communities by PCR-single-strand-conformation polymorphism. Appl Environ Microbiol 1996; 62: 3112-20.
36. Armougom F, Henry M, Vialettes B, Raccah D, Raoult D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and methanogens in anorexic patients. PLoS ONE 2009; 4: 10
37. Walter J, Hertel C, Tannock GW, Lis CM, Munro K, Hammes WP. Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol 2001; 67: 2578-85.
38. Pitcher DG, Saunders NA, Owen RJ. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett Appl Microbiol 1989; 8: 151-6.
39. - species of resveratrol and piceatannol investigated by deuterium labelling and accurate mass measurements. Rapid Commun Mass Spectrom 2008; 22: 3867-72.
40. Morishetti KK, Sripadi P, Mariappanadar V, Ren J. Generation and characterization of distonic dehydrophenoxide radical anions under electrospray and atmospheric pressure chemical ionizations. Int J Mass Spectrom 2011; 299: 169-77.
41. Attygalle AB, Ruzicka J, Varughese D, Bialecki JB, Jafri S. Low-energy collision-induced fragmentation of negative ions derived from ortho-, meta-, and para-hydroxyphenyl carbaldehydes, ketones, and related compounds. J Mass Spectrom 2007; 42: 1207-17.
42. Reeks LB, Eichinger PCH, Bowie JH. ortho-Rearrangements of o-alkylphenoxide anions. Rapid Commun Mass Spectrom 1993; 7: 286-7.
43. Pryce RJ. Metabolism of lunularic acid to a new plant stilbene by Lunularia cruciata. Phytochemistry 1972; 11: 1355-64.
44. Turroni F, Ribbera A, Foroni E, van Sinderen D, Ventura M. Human gut microbiota and bifidobacteria: from composition to functionality. Antonie van Leeuwenhoek 2008; 94: 35-50.
45. Maccaferri S, Biagi E, Brigidi P. Metagenomics: key to human gut microbiota. Dig Dis 2011; 29: 525-30.
46. Jackson RL, Greiwe JS, Schwen RJ. Emerging evidence of the health benefits of S-equol, an estrogen receptor b agonist. Nutr Rev 2011; 69: 432-48.
47. Lund TD, Blake C, Bu L, Hamaker AN, Lephart ED. Equol an iso-flavonoid: potential for improved prostate health, in vitro and in vivo evidence. Reprod Biol Endocrinol 2011; 9:4.
48. Gakh AA, Anisimova NY, Kiselevsky MV, Sadovnikov SV, Stankov IN, Yudin MV, Rufanov KA, Krasavin MY, Sosnov AV. Dihydro-resveratrol - a potent dietary polyphenol. Bioorg Med Chem Lett 2010; 20: 6149-51.
49. Braune A, Bunzel M, Yonekura R, Blaut M. Conversion of dehy-drodiferulic acids by human intestinal microbiota. J Agric Food Chem 2009; 57: 3356-62.
50. Struijs K, Vincken JP, Gruppen H. Bacterial conversion of secoiso-lariciresinol and anhydrosecoisolariciresinol. J Appl Microbiol 2009; 107: 308-17.
51. Jin J-S, Zhao Y-F, Nakamura N, Akao T, Kakiuchi N, Min B-S, Hattori M. Enantioselective dehydroxylation of enterodiol and enterolactone precursors by human intestinal bacteria. Biol Pharm Bull 2007; 30: 2113-9.
52. Wang LQ, Meselhy MR, Li Y, Qin GW, Hattori M. Human intestinal bacteria capable of transforming secoisolariciresinol diglucoside to mammalian lignans, enterodiol and enterolactone. Chem Pharm Bull (Tokyo) 2000; 48: 1606-10.
53. Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006; 47: 241-59.
54. Renouf M, Guy PA, Marmet C, Fraering A-L, Longet K, Moulin J, Enslen M, Barron D, Dionisi F, Cavin C, et al. Measurement of caffeic and ferulic acid equivalents in plasma after coffee consumption: small intestine and colon are key sites for coffee metabolism. Mol Nutr Food Res 2010; 54: 760-6.
55. Matthies A, Blaut M, Braune A. Isolation of a human intestinal bacterium capable of daidzein and genistein conversion. Appl Environ Microbiol 2009; 75: 1740-4.
56. Maruo T, Sakamoto M, Ito C, Toda T, Benno Y. Adlercreutzia equo-lifaciens gen. nov., sp nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella. Int J Syst Evol Microbiol 2008; 58: 1221-7.
57. Kutschera M, Engst W, Blaut M, Braune A. Isolation of catechin-converting human intestinal bacteria. J Appl Microbiol 2011; 111: 165-75.
58. Clavel T, Henderson G, Engst W, Dore J, Blaut M. Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolaricir-esinol diglucoside. FEMS Microbiol Ecol 2006; 55: 471-8.